Life sciences news
-
OXURION announces positive results from Part A of Phase 2 Study evaluating THR-149 for treatment of Diabetic Macular Edema (DME)
Thursday September 30th 2021
Read more
-
Bone Therapeutics signs research partnership with Implant Therapeutics to access induced Pluripotent Stem Cells (iPSC)
Wednesday September 29th 2021
Read more
-
Donesta® Phase III: recruitment completion of American study and additional recruitment in the European study
Wednesday September 22nd 2021
Read more
-
Mithra announces an update on PeriNesta®
Wednesday September 22nd 2021
Read more
-
Galapagos announces positive CHMP opinion for Jyseleca® (filgotinib) for the treatment of adults with moderately to severely active ulcerative colitis
Friday September 17th 2021
Read more
-
Flamingo Therapeutics expands alliance with Ionis Pharmaceuticals to develop RNA-targeted therapies for oncology
Thursday September 9th 2021
Read more
-
Newton Biocapital invests in PRISM BioLab to support development of a unique peptide mimetic technology platform to discover new drugs for intractable diseases
Thursday September 9th 2021
Read more
-
ViroVet and The Pirbright Institute are first to demonstrate efficacy of antivirals in ASFV infected pigs
Thursday September 9th 2021
Read more
-
Become a flanders.bio member
Your news here?
-
Publication of Positive Phase 1 Clinical Data evaluating THR-687 for Treatment of DME in Ophthalmology Science
Tuesday August 17th 2021
Read more
-
Belgian MedTech start-up regenerates cartilage
Thursday June 24th 2021
Read more
-
Investment in Flow Cytometry unlocks the secrets of single cells
Thursday May 20th 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
